Selected article for: "candidate vaccine and vaccine candidate"

Author: Hualan Chen
Title: Susceptibility of ferrets, cats, dogs, and different domestic animals to SARS-coronavirus-2
  • Document date: 2020_3_31
  • ID: mo4luyx6_15
    Snippet: Several studies have reported that SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) as its receptor to enter cells (3, (28) (29) (30) . ACE2 is mainly expressed in type II pneumocytes and serous epithelial cells of tracheo-bronchial submucosal glands in ferrets (25) ; therefore, the underlying mechanism that prevents the replication of SARS-CoV-2 in the lower respiratory tract of ferrets remains to be investigated. The fact that SARS-CoV-2 .....
    Document: Several studies have reported that SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) as its receptor to enter cells (3, (28) (29) (30) . ACE2 is mainly expressed in type II pneumocytes and serous epithelial cells of tracheo-bronchial submucosal glands in ferrets (25) ; therefore, the underlying mechanism that prevents the replication of SARS-CoV-2 in the lower respiratory tract of ferrets remains to be investigated. The fact that SARS-CoV-2 replicates efficiently in the upper respiratory tract of ferrets makes them a candidate animal model for evaluating antiviral drugs or vaccine candidates against COVID-19.

    Search related documents:
    Co phrase search for related documents
    • animal model and efficiently replicate: 1
    • animal model and epithelial cell: 1, 2, 3, 4, 5, 6, 7, 8
    • animal model and respiratory tract: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • animal model and SARS replication: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • animal model and vaccine candidate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • antiviral drug and efficiently replicate: 1
    • antiviral drug and epithelial cell: 1, 2, 3, 4, 5, 6, 7, 8
    • antiviral drug and respiratory tract: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral drug and SARS replication: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral drug and vaccine candidate: 1, 2
    • efficiently replicate and epithelial cell: 1
    • efficiently replicate and respiratory tract: 1, 2
    • efficiently replicate and SARS efficiently replicate: 1, 2, 3, 4, 5
    • efficiently replicate and SARS replication: 1, 2, 3, 4
    • efficiently replicate and vaccine candidate: 1, 2
    • epithelial cell and SARS efficiently replicate: 1
    • epithelial cell and SARS replication: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • epithelial cell and type II pneumocyte: 1
    • epithelial cell and vaccine candidate: 1, 2, 3